Elijah Darnell to Humans
This is a "connection" page, showing publications Elijah Darnell has written about Humans.
Connection Strength
0.212
-
Ibrutinib exposure correlates with improved efficacy of CAR T cells in patients with mantle cell lymphoma. Blood Adv. 2026 Feb 24; 10(4):1023-1034.
Score: 0.031
-
Tumor burden in ZUMA-7: less is more. Blood. 2024 06 13; 143(24):2441-2442.
Score: 0.028
-
Two years later: CD19 CAR-T going the distance. Blood. 2024 02 01; 143(5):379-380.
Score: 0.027
-
German CARs keeping pace. Blood. 2022 07 28; 140(4):296-298.
Score: 0.025
-
Preoperative cholangitis is an independent risk factor for mortality in patients after pancreatoduodenectomy for pancreatic cancer. Am J Surg. 2021 01; 221(1):134-140.
Score: 0.021
-
IL-1Rahigh-IL-4low-IL-13low: A Novel Plasma Cytokine Signature Associated with Olfactory Dysfunction in Older US Adults. Chem Senses. 2020 05 29; 45(5):407-414.
Score: 0.021
-
Immune-Related Adverse Events (irAEs): Diagnosis, Management, and Clinical Pearls. Curr Oncol Rep. 2020 03 21; 22(4):39.
Score: 0.021
-
Tuning CAR-T cells by targeting cancer-associated glycan in pancreatic cancer. Nat Commun. 2025 Dec 10; 16(1):11246.
Score: 0.008
-
In vivo CRISPR screens identify modifiers of CAR T cell function in myeloma. Nature. 2025 Oct; 646(8086):953-962.
Score: 0.008
-
Secretion of a VEGF-Blocking scFv Enhances CAR T-cell Potency. Cancer Immunol Res. 2025 Aug 01; 13(8):1132-1144.
Score: 0.008
-
IFN-?-resistant CD28 CAR T cells demonstrate increased survival, efficacy, and durability in multiple murine tumor models. Sci Transl Med. 2025 Jun 04; 17(801):eadp8166.
Score: 0.007
-
IgG testing, immunoglobulin replacement therapy, and infection outcomes in patients with CLL or NHL: real-world evidence. Blood Adv. 2024 08 27; 8(16):4239-4249.
Score: 0.007